Morgan Stanley Virax Biolabs Group LTD Transaction History

Morgan Stanley

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$0.57 - $28.6 $486 - $24,395	853 New	853 $0

Ticker VRAX
Exchange
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,374,100
Market Cap $22.4M
Description
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid te...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.